14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.24 $2.30 Wednesday, 24th Apr 2024 ATOS stock ended at $1.50. This is 0.671% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 7.77% from a day low at $1.48 to a day high of $1.60.
90 days $0.774 $2.30
52 weeks $0.590 $2.30

Historical Atossa Genetics Inc. prices

Date Open High Low Close Volume
Aug 17, 2021 $3.08 $3.26 $3.04 $3.23 5 628 788
Aug 16, 2021 $3.18 $3.21 $3.04 $3.13 4 285 692
Aug 13, 2021 $3.31 $3.34 $3.15 $3.22 5 710 009
Aug 12, 2021 $3.20 $3.46 $3.16 $3.31 8 308 869
Aug 11, 2021 $3.30 $3.30 $3.08 $3.18 7 152 383
Aug 10, 2021 $3.26 $3.36 $3.24 $3.29 4 368 218
Aug 09, 2021 $3.37 $3.44 $3.30 $3.33 4 550 307
Aug 06, 2021 $3.37 $3.40 $3.25 $3.38 5 469 054
Aug 05, 2021 $3.17 $3.41 $3.08 $3.33 8 785 691
Aug 04, 2021 $2.89 $3.45 $2.87 $3.15 21 397 363
Aug 03, 2021 $2.91 $2.94 $2.75 $2.89 8 884 919
Aug 02, 2021 $2.97 $3.07 $2.88 $2.91 11 914 251
Jul 30, 2021 $3.70 $3.72 $2.80 $2.99 40 849 275
Jul 29, 2021 $4.00 $4.18 $3.88 $3.90 6 549 675
Jul 28, 2021 $3.89 $4.11 $3.84 $3.95 7 448 867
Jul 27, 2021 $3.95 $4.01 $3.71 $3.92 7 995 789
Jul 26, 2021 $4.08 $4.48 $3.84 $3.96 11 934 030
Jul 23, 2021 $4.04 $4.57 $3.78 $4.18 21 509 353
Jul 22, 2021 $4.18 $4.23 $3.94 $4.11 8 025 891
Jul 21, 2021 $4.00 $4.42 $4.00 $4.24 14 772 281
Jul 20, 2021 $3.94 $4.02 $3.75 $3.94 11 580 735
Jul 19, 2021 $4.12 $4.24 $3.71 $3.90 24 822 978
Jul 16, 2021 $5.68 $5.82 $4.32 $4.50 44 196 914
Jul 15, 2021 $6.24 $6.70 $5.49 $5.62 19 017 724
Jul 14, 2021 $6.78 $7.15 $5.93 $6.35 28 193 067
Click to get the best stock tips daily for free!

About Atossa Genetics Inc.

Atossa Genetics Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patien... ATOS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT